Cesar Rodriguez Valdes, MD; Binod Dhakal, MD; Appalanaidu Sasapu MD, FACP, and Leo Shunyakov, MD, discuss how optimizing care transitions for multiple myeloma patients receiving bispecific therapy requires a multifaceted approach involving standardized protocols, enhanced communication between academic and community oncologists, patient-centered care models, and innovative technologies to address current challenges and future needs in ensuring seamless, high-quality care across all treatment settings.